problems with glp 1 drugs As GLP-1 continue to gain popularity for weight loss, a lesser-known side effect is drawing attention from podiatrists: “Ozempic feet.” https://ktla.com/news/ozempic-feet-the-latest-side-effect-among-glp-1 -users-doctors-warn GLP-1 receptor agonists | How

The appetite suppression, metabolic changes, and gut hormone modulation provided by tirzepatide reverse when the medication is discontinued

- Potentially reduce the risk of heart-related issues in specific patient groups

"For patients who didn't do psychological work alongside the medicine, this is the worst-case convergence that tends to produce the most distress and the most rapid regain," he says

Study Finds GLP-1 Drugs Like Ozempic and Wegovy Not Linked to Pancreatic Cancer Study Finds GLP-1 Drugs Like Ozempic and Wegovy Not Linked to Pancreatic Cancer Recent research findings indicate that drugs belonging to the GLP-1RA class do not pose an increased risk of pancreatic cancer

FDA statement on enforcement priorities regarding compounded GLP-1 receptor agonist products [Press release]

In the sensitivity analysis, the rates of major birth defects, when all major anomalies irrespective of aetiology were included, were 3.1% in the GLP1-RA exposed group and 4.2% in the reference group with diabetes